Related Experiment Video

Updated: Jul 15, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Cardiac magnetic resonance in Chagas' disease

Carlos Eduardo Rochitte1, Marcelo Souto Nacif, Amarino Carvalho de Oliveira Júnior

  • 1Cardiology Department of Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil. rochitte@incor.usp.br

Artificial Organs
|April 18, 2007
PubMed

Insights

Cardiac magnetic resonance (CMR) accurately detects myocardial fibrosis in Chagas' heart disease. This imaging tool shows promise for early screening and evaluating new treatments for this common cause of death.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • Chagas' disease (CD), caused by Trypanosoma cruzi, is a major cause of mortality in Latin America.
  • Cardiac involvement, including myocarditis and myocardial fibrosis (MF), is critical to patient prognosis in CD.
  • Cardiac magnetic resonance (CMR) is highly effective for detecting MF in various cardiomyopathies, including Chagas' heart disease.

Purpose of the Study:

  • To discuss the current clinical applications of CMR in evaluating Chagas' disease.
  • To explore the future potential of CMR as a screening tool for early myocardial involvement in CD.
  • To highlight CMR's role in facilitating research into novel therapeutic strategies for CD.

Main Methods:

  • Review of current clinical applications of CMR in Chagas' heart disease.
  • Discussion of CMR's advanced imaging capabilities for tissue characterization (edema, fat).
  • Exploration of CMR's potential for early detection and screening of myocardial involvement.

Main Results:

  • CMR is the most accurate method for detecting myocardial fibrosis in Chagas' heart disease.
  • CMR provides comprehensive evaluation of cardiac morphology, function, and tissue characteristics.
  • The study emphasizes CMR's utility in assessing Chagas' heart disease.

Conclusions:

  • CMR is a valuable tool for evaluating Chagas' heart disease, particularly for detecting myocardial fibrosis.
  • Future applications of CMR include early screening for subclinical myocardial involvement.
  • CMR can aid in the development and testing of new therapies to alter the natural history of Chagas' disease.

More Related Videos

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Cardiac Magnetic Resonance Imaging at 7 Tesla09:14

Cardiac Magnetic Resonance Imaging at 7 Tesla

Published on: January 6, 2019

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...